Viking Therapeutics’ positive results for oral weight-loss drug has analysts backing buy ratings
Data from a Phase 1 trial is the latest bullish news from the biotech that may offer cheap entry to weight-loss mania.
Momentum stocks are outperforming S&P 500 by widest margin since 2008. Investors should be concerned.
Momentum stocks are coming off their best stretch of outperformance in years — since just before the financial crisis, in fact. That’s making some investors...
Carnival provides estimate of what the Baltimore bridge collapse will cost it
Carnival Corp.’s stock dropped Wednesday after the cruise operator reported an narrower-than-expected fiscal first-quarter loss but also provided an estimate for what the collapse of...
Wells Fargo’s rally sparks KBW downgrade after it outpaces other bank stocks
Investors have been bidding up the stock partly on speculation that its asset cap imposed by the Federal Reserve may be lifted in the next...
GameStop’s demise could come later this decade, analyst says
GameStop Corp., which reported a significant sales decline its fourth-quarter results late Tuesday, could meet its demise before the end of this decade, according to...
FDA approves Merck’s drug for rare, deadly lung condition
The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of...
Ford sees opportunity for Mustang as competitors abandon V8 engines
The optimism follows the Chevrolet Camaro and Dodge Challenger — the Mustang's closest American competitors — ended production in December.
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
Moderna will chart its post-Covid future Wednesday during its fifth annual "Vaccines Day," an investor event in Boston.
Costco and Sam’s Club’s smaller rival BJ’s Wholesale will open more clubs in Southeast
The membership warehouse BJ's Wholesale said it plans to open a dozen clubs this year and 10 to 12 clubs each year going forward.